BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 36871635)

  • 1. The metabolic crosstalk between PIN1 and the tumour microenvironment.
    Caligiuri I; Vincenzo C; Asano T; Kumar V; Rizzolio F
    Semin Cancer Biol; 2023 Jun; 91():143-157. PubMed ID: 36871635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Multiple Roles of Peptidyl Prolyl Isomerases in Brain Cancer.
    Stifani S
    Biomolecules; 2018 Oct; 8(4):. PubMed ID: 30314361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphorylation-dependent prolyl isomerization: a novel signaling regulatory mechanism.
    Zhou XZ; Lu PJ; Wulf G; Lu KP
    Cell Mol Life Sci; 1999 Nov; 56(9-10):788-806. PubMed ID: 11212339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of eukaryotic protein kinases by Pin1, a peptidyl-prolyl isomerase.
    Chen XR; Igumenova TI
    Adv Biol Regul; 2023 Jan; 87():100938. PubMed ID: 36496344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of phosphorylation in determining the backbone dynamics of the serine/threonine-proline motif and Pin1 substrate recognition.
    Schutkowski M; Bernhardt A; Zhou XZ; Shen M; Reimer U; Rahfeld JU; Lu KP; Fischer G
    Biochemistry; 1998 Apr; 37(16):5566-75. PubMed ID: 9548941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxygen-independent stabilization of HIF-2α in breast cancer through direct interaction with peptidyl-prolyl cis-trans isomerase NIMA-interacting 1.
    Guillen-Quispe YN; Kim SJ; Saeidi S; Zhou T; Zheng J; Kim SH; Fang X; Chelakkot C; Rios-Castillo ME; Shin YK; Surh YJ
    Free Radic Biol Med; 2023 Oct; 207():296-307. PubMed ID: 37473874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolyl isomerase Pin1: a catalyst for oncogenesis and a potential therapeutic target in cancer.
    Ryo A; Liou YC; Lu KP; Wulf G
    J Cell Sci; 2003 Mar; 116(Pt 5):773-83. PubMed ID: 12571275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphorylation-dependent proline isomerization catalyzed by Pin1 is essential for tumor cell survival and entry into mitosis.
    Rippmann JF; Hobbie S; Daiber C; Guilliard B; Bauer M; Birk J; Nar H; Garin-Chesa P; Rettig WJ; Schnapp A
    Cell Growth Differ; 2000 Jul; 11(7):409-16. PubMed ID: 10939594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Peptidyl-Prolyl
    Anto NP; Muraleedharan A; Nath PR; Sun Z; Keasar C; Livneh E; Braiman A; Altman A; Kong KF; Isakov N
    Front Immunol; 2023; 14():1126464. PubMed ID: 36969236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advances of Pin1 inhibitors as potential anticancer agents.
    Bai Y; Yuan Z; Yuan S; He Z
    Bioorg Chem; 2024 Mar; 144():107171. PubMed ID: 38325131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of peptidyl-prolyl isomerase 1 depletion in animal models of prion diseases.
    Legname G; Virgilio T; Bistaffa E; De Luca CMG; Catania M; Zago P; Isopi E; Campagnani I; Tagliavini F; Giaccone G; Moda F
    Prion; 2018 Mar; 12(2):127-137. PubMed ID: 29676205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequence-specific and phosphorylation-dependent proline isomerization: a potential mitotic regulatory mechanism.
    Yaffe MB; Schutkowski M; Shen M; Zhou XZ; Stukenberg PT; Rahfeld JU; Xu J; Kuang J; Kirschner MW; Fischer G; Cantley LC; Lu KP
    Science; 1997 Dec; 278(5345):1957-60. PubMed ID: 9395400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pin1-dependent prolyl isomerization regulates dephosphorylation of Cdc25C and tau proteins.
    Zhou XZ; Kops O; Werner A; Lu PJ; Shen M; Stoller G; Küllertz G; Stark M; Fischer G; Lu KP
    Mol Cell; 2000 Oct; 6(4):873-83. PubMed ID: 11090625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Unexpected roles of the peptidyl-prolyl cis/trans isomerase Pin1].
    Lavoie SB; Albert AL; Vincent M
    Med Sci (Paris); 2003 Dec; 19(12):1251-8. PubMed ID: 14691750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pin1 promotes transforming growth factor-beta-induced migration and invasion.
    Matsuura I; Chiang KN; Lai CY; He D; Wang G; Ramkumar R; Uchida T; Ryo A; Lu K; Liu F
    J Biol Chem; 2010 Jan; 285(3):1754-64. PubMed ID: 19920136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Recent advances in the study of pin1 and its inhibitors].
    Zhang CJ; Zhang ZH; Xu BL; Wang YL
    Yao Xue Xue Bao; 2008 Jan; 43(1):9-17. PubMed ID: 18357725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional conservation of phosphorylation-specific prolyl isomerases in plants.
    Yao JL; Kops O; Lu PJ; Lu KP
    J Biol Chem; 2001 Apr; 276(17):13517-23. PubMed ID: 11118438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-150-5p inhibits the proliferation and invasion of human larynx epidermiod cancer cells though regulating peptidyl-prolyl cis/trans isomerase.
    Chen H; Cai X; Du B; Cai J; Luo Z
    Braz J Otorhinolaryngol; 2023; 89(3):383-392. PubMed ID: 37105032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolyl isomerase, Pin1: new findings of post-translational modifications and physiological substrates in cancer, asthma and Alzheimer's disease.
    Takahashi K; Uchida C; Shin RW; Shimazaki K; Uchida T
    Cell Mol Life Sci; 2008 Feb; 65(3):359-75. PubMed ID: 17965833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peptidyl-Prolyl cis/trans Isomerase NIMA-Interacting 1 as a Therapeutic Target in Hepatocellular Carcinoma.
    Kim G; Kim JY; Choi HS
    Biol Pharm Bull; 2015; 38(7):975-9. PubMed ID: 26133706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.